Skip to main content

Table 1 Baseline characteristics before (Group 1) and after the implementation of the Life-Sustaining Treatment Decisions Act (Group 2)

From: Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act

Characteristics Group 1
(n = 943)
Group 2
(n = 891)
p-value
  No. (%) No. (%)  
Age at death (Mean ± SD) 64.9 ± 10.9 66.1 ± 11.1 0.906
Sex, male 634 (67.2 %) 564 (63.3 %) 0.078
Primary site of cancer Head and neck cancer 31 (3.3 %) 18 (2.0 %) 0.124
Esophageal cancer 27 (2.9 %) 15 (1.7 %)
Lung cancer 254 (26.98 %) 260 (29.2 %)
Breast cancer 48 (5.1 %) 56 (6.3 %)
Stomach cancer 106 (11.2 %) 90 (10.1 %)
Colorectal cancer 95 (10.1 %) 94 (10.5 %)
Hepatobiliary cancer 292 (31.0 %) 253 (28.4 %)
Pancreatic cancer 90 (9.5 %) 105 (11.8 %)
Education ≤ 12 years 816 (86.5 %) 781 (87.7 %) 0.935
> 12 years 122 (12.9 %) 94 (10.5 %)
Healthcare insurance NHI 880 (93.3 %) 853 (95.7 %) 0.018
Medical aid 63 (6.7 %) 37 (4.2 %)
Received chemotherapy 475 (50.4 %) 486 (54.5 %) 0.076
  1. SD standard deviation; NHI National Health Insurance